Investors beware - Recensione dipendente - Dipendente anonimo presso AccessHope

1,0
29 feb 2024
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Remote role Incredible mission to help those with cancer

Svantaggi

Poor management Blame almost everything on a start up environment HR dept lacking… just lacking… a lot Dishonest feedback and lack of transparency amongst leadership Employees that speak up or do their job well are usually let go or pushed out. Prefer to hire nurses that don’t question things

Esplora altre recensioni su AccessHope

5,0
15 feb 2024
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Organization truly changing the cancer field and wonderful place to work!

Svantaggi

As with any small company shifting priorities can be challenging

1,0
29 nov 2025
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Good cause for underserved patients

Svantaggi

Upper Management regime changes frequently. They hire their friends who have no domain experience and end up just attending meetings and bringing no value. They will work you 60 hour weeks and the second you complain you get blacklisted and put on the annual layoff list. This is a repetitive cycle that keeps the company from progressing in data science and analytics. They will never be more than a basic second opinion company trying to hold on to break-even status and becoming irrelevant in the new AI driven marketplace.

1
Vedi recensioni per: Utile|Valutazione|Data|Tutto